Careus Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 07-12-2024
- Revenue 34.08%
(FY 2022)
- Profit 21.59%
(FY 2022)
- Ebitda 3.63%
(FY 2022)
- Net Worth 24.77%
(FY 2022)
- Total Assets 29.72%
(FY 2022)
About Careus Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Surendra Bhatnagar and Rakhi Bhatnagar serve as directors at the Company.
- CIN/LLPIN
U45400UR2016PTC007093
- Company No.
007093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Careus Pharmaceutical Private Limited offer?
Careus Pharmaceutical Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Herbal Soaps, Ayurvedic & Herbal Health Supplement, Herbal Juice, Common Disease Medicines, Eye Drops, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Bath Tools, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Careus Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Bhatnagar  | Director | 25-May-2016 | Current |
| Rakhi Bhatnagar | Director | 14-Jul-2022 | Current |
Financial Performance of Careus Pharmaceutical.
Careus Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.08% increase. The company also saw a substantial improvement in profitability, with a 21.59% increase in profit. The company's net worth Soared by an impressive increase of 24.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Careus Pharmaceutical?
In 2021, Careus Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 13 Oct 2016 | ₹4.00 M | Open |
How Many Employees Work at Careus Pharmaceutical?
Unlock and access historical data on people associated with Careus Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Careus Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Careus Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
